Maxime Breban Selected Research

Maxime Breban Research Topics

Disease

17	Ankylosing Spondylitis 01/2020 - 09/2002
9	Spondylarthropathies 01/2016 - 03/2002
8	Inflammation (Inflammations) 01/2021 - 03/2003
7	Axial Spondyloarthritis 01/2022 - 07/2014
6	Back Pain (Backache) 01/2021 - 08/2011
5	Psoriatic Arthritis 01/2016 - 09/2002
5	Arthritis (Polyarthritis) 05/2015 - 02/2004
4	Uveitis 01/2016 - 04/2004
3	Pain (Aches) 01/2022 - 03/2002
3	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021 - 07/2006
2	Dysbiosis 07/2022 - 01/2021
2	Colitis 01/2021 - 10/2012
2	Spondylarthritis (Spinal Arthritis) 10/2012 - 07/2007
2	Latent Tuberculosis 12/2007 - 01/2006
2	Rheumatoid Arthritis 11/2006 - 01/2006
2	Necrosis 01/2006 - 09/2002
2	Crohn Disease (Crohn's Disease) 01/2006 - 10/2003
1	Fatigue 01/2022
1	Sepsis (Septicemia) 01/2021
1	COVID-19 01/2021
1	Endotoxemia 01/2021
1	Dacryocystitis (Dacryoadenitis) 01/2018
1	Adult-Onset Still's Disease 01/2018
1	Basal Cell Carcinoma (Rodent Ulcer) 03/2016
1	Reinfection 03/2016
1	Subacute Thyroiditis (Thyroiditis, De Quervain) 01/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2015
1	Disease Progression 06/2015
1	Bone Resorption 06/2015
1	Serum Sickness 06/2013
1	Sjogren's Syndrome (Sjogren Syndrome) 06/2013
1	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2013
1	Enthesopathy 04/2013
1	Narcolepsy 01/2013
1	Arthralgia (Joint Pain) 12/2012
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2008
1	Lymphoma (Lymphomas) 03/2008
1	Disease Susceptibility (Diathesis) 07/2007
1	Infections 01/2006
1	Rheumatic Diseases (Rheumatism) 04/2005
1	Ulcerative Colitis 11/2003
1	Tuberculosis (Tuberculoses) 10/2003
1	Atrophy 03/2003
1	Achlorhydria (Hypochlorhydria) 03/2003
1	Neoplasms (Cancer) 03/2003
1	Gastritis 03/2003
1	Atrophic Gastritis 03/2003
1	Synovitis 09/2002

Drug/Important Bio-Agent (IBA)

16	HLA-B27 Antigen (HLA B27 Antigen)IBA 07/2022 - 02/2004
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 03/2003
6	Infliximab (Remicade)FDA Link 03/2016 - 03/2002
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 11/2003
3	Pharmaceutical PreparationsIBA 01/2021 - 09/2015
3	CytokinesIBA 01/2021 - 03/2003
3	AntigensIBA 01/2021 - 05/2007
3	Peptides (Polypeptides)IBA 01/2020 - 02/2004
3	Interleukin-1 (Interleukin 1)IBA 01/2018 - 07/2006
3	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 01/2016 - 12/2012
3	HLA-B Antigens (HLA-B)IBA 05/2015 - 08/2011
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 01/2020
2	InterleukinsIBA 01/2021 - 03/2003
2	Biomarkers (Surrogate Marker)IBA 11/2017 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 03/2003
2	Proteins (Proteins, Gene)FDA Link 07/2007 - 03/2003
1	Janus Kinase InhibitorsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021
1	Antirheumatic Agents (DMARD)IBA 01/2021
1	Biological ProductsIBA 01/2016
1	Tumor Necrosis Factor InhibitorsIBA 09/2015
1	Adalimumab (Humira)FDA Link 07/2015
1	AminopeptidasesIBA 07/2013
1	Rituximab (Mabthera)FDA Link 06/2013
1	Prostaglandins AIBA 04/2013
1	C-Reactive ProteinIBA 04/2013
1	CholesterolIBA 04/2013
1	Triglycerides (Triacylglycerol)IBA 04/2013
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2013
1	OX40 LigandIBA 01/2013
1	Cathepsin HIBA 01/2013
1	OrexinsIBA 01/2013
1	Etanercept (Enbrel)FDA Link 03/2008
1	Tuberculin (PPD)IBA 12/2007
1	HLA-B*07:02 antigenIBA 07/2007
1	HLA-B*27:05 antigenIBA 07/2007
1	HLA-B*27:09 antigenIBA 07/2007
1	ClusterinIBA 11/2006
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2003
1	Therapeutic UsesIBA 10/2003
1	Messenger RNA (mRNA)IBA 10/2003
1	Free RadicalsIBA 03/2003
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 03/2003
1	AcidsIBA 03/2003
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2003
1	Virulence Factors (Pathogenicity Factors)IBA 03/2003
1	GastrinsIBA 03/2003

Therapy/Procedure

7	Therapeutics 03/2016 - 09/2002
1	Drug Therapy (Chemotherapy) 01/2022
1	Biological Therapy 01/2021
1	Injections 04/2005